Drug Shortage Report for YERVOY
| Report ID | 198397 |
| Drug Identification Number | 02379384 |
| Brand name | YERVOY |
| Common or Proper name | Ipilimumab |
| Company Name | BRISTOL-MYERS SQUIBB CANADA |
| Market Status | MARKETED |
| Active Ingredient(s) | IPILIMUMAB |
| Strength(s) | 5MG |
| Dosage form(s) | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1x40ml |
| ATC code | L01XC |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-07-12 |
| Actual start date | 2023-07-12 |
| Estimated end date | Unknown |
| Actual end date | 2023-08-21 |
| Shortage status | Resolved |
| Updated date | 2023-08-22 |
| Company comments | shortage only affects 200MG strength |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
| Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2023-08-22 | English | Compare |
| v7 | 2023-08-21 | French | Compare |
| v6 | 2023-08-21 | English | Compare |
| v5 | 2023-07-13 | English | Compare |
| v4 | 2023-07-12 | French | Compare |
| v3 | 2023-07-12 | French | Compare |
| v2 | 2023-07-12 | English | Compare |
| v1 | 2023-07-12 | English | Compare |
Showing 1 to 8 of 8